NEW YORK (GenomeWeb News) – Investigators at Hartford Hospital's Genetics Research Center and Institute of Living will use a nearly $1.3 million federal grant to study the use of pharmacogenomic approaches in choosing medications for psychiatric patients.

The GRC and IOL researchers plan to use the funds from the Agency for Healthcare Research and Quality to find out whether the use of genetic testing to select medications affects psychiatric patients' length of stay in the hospital or their readmission rates, Hartford Hospital said on Tuesday.